Ab Initio appoints new COO & Head of Manufacturing

Ab Initio is pleased to announce the appointment of Dr William Glover as its Chief Operating Officer and Head of Manufacturing.

Will has over 20 years experience in the area of pharmaceutical product design and manufacturing and a PhD in Pharmaceutics from the University of Sydney. In his previous roles, Will has worked in process development chemistry at 3M, Program Manager at Nanomaterials Technology in Singapore, Project and QC Manager at GlaxoSmithCline in Australia, and New Product Introduction Manager at Phebra in Sydney. Will is joining our expanding team as COO and be involved in the day-to-day operations, as well as the the finalisation of Ab Initio’s Manufacturing plant in Glebe.

Ab Initio Pharma is a pharmaceutical formulation R&D and Manufacturing company based in Sydney that specialises in the development and manufacture of novel therapeutic products for innovators that wish to take their molecules through to the clinic.